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Duchenne muscular dystrophy (DMD) is a X-linked genetic disease in which the absence
of dystrophin leads to progressive lethal skeletal muscle degeneration. It has been
demonstrated that among genes which are important for proper muscle development
and function, micro-RNAs (miRNAs) play a crucial role. Moreover, altered levels of
miRNAs were found in several muscular disorders, including DMD. A specific group
of miRNAs, whose expression depends on dystrophin levels and whose deregulation
explains several DMD pathogenetic traits, has been identified. Here, we addressed
whether the anabolic activity of mIGF-1 on dystrophic muscle is associated with
modulation of microRNAs expression. We demonstrated that some microRNAs are
strictly linked to the dystrophin expression and are not modulated by mIGF-1 expression.
In contrast, local expression of mIGF-1 promotes the modulation of other microRNAs,
such as miR-206 and miR-24, along with the modulation of muscle specific genes,
which are associated with maturation of regenerating fibers and with the stabilization
of the differentiated muscle phenotype. These data suggest that mIGF-1, modifying the
expression of some of the active players of muscle homeostasis, is able, even in absence
of dystrophin expression, to activate circuitries that confer robustness to dystrophic
muscle.
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Introduction
Duchenne muscular dystrophy (DMD) is an X-linked genetic disease caused by mutations in
the dystrophin gene, leading to progressive lethal muscle degeneration, chronic inflammatory
response, and fibrosis (Deconinck and Dan, 2007).
Recent works have shown that micro-RNAs (miRNAs), which are important regulatory elements
for proper muscle development and function (Eisenberg et al., 2009; Güller and Russell, 2010;
Sharma et al., 2014), might play crucial roles in the pathogenesis of several muscular disorders,
including DMD (Eisenberg et al., 2007; Chen et al., 2009). MiRNAs are small, ∼22 nucleotides
long, non coding RNA that function as regulatory molecules, silencing their cognate target genes
(Bartel, 2004).
In a previous work, we contributed to identify a specific group of miRNAs whose expression
depends on dystrophin levels and whose deregulation explains several DMD pathogenic traits
(Cacchiarelli et al., 2010). This class of miRNAs, poorly expressed in mdx, was upregulated
in exon-skipping-treated animals and included muscle specific (miR-1 and miR-133) and more
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ubiquitous (miR-29 and miR-30) miRNAs. Moreover, the
negative modulation of the inflammatory miR-223 and the
up-regulation of miR-29, which controls collagen deposition,
was consistent with the observed amelioration of the dystrophin
phenotype due to the rescue of dystrophin expression by exon-
skipping approach (Cacchiarelli et al., 2010). In contrast, the
restricted expression of the myomiR 206 in activated satellite
cells before the onset of dystrophin synthesis, suggested that
miR-206 is independent from the Dystrophin/nNOS-mediated
pathway. Moreover, it has been demonstrated a common micro-
RNA signature in skeletal muscle damage and regeneration
induced by DMD and acute ischemia (Greco et al., 2009),
suggesting an important role of miRNAs in physiopathological
pathways regulating muscle response to damage and
regeneration.
Among growth factors, the insulin-like growth factors 1
(IGF-1) has been implicated in many anabolic pathways in
skeletal muscle. Different studies on the roles of IGF-1 isoforms
in skeletal muscle growth and differentiation have provided new
insights into the function of these signaling molecules in muscle
homeostasis, and in the control of skeletal muscle growth and
regeneration (Scicchitano et al., 2009).
We previously demonstrated that muscle restricted mIGF-1
transgene (MLC/mIGF-1) sustained muscle hypertrophy and
regeneration in young and senescent skeletal muscle (Musarò
et al., 2001; Pelosi et al., 2007), enhanced the recruitment
of circulating stem cells in injured muscle (Musarò et al.,
2004) and counteracted muscle wasting in mdx dystrophic
mice (Barton et al., 2002). In particular, we found a reduction
in myonecrosis and fibrosis in the muscles of mdx/mIGF-1
mice compared with age-matched mdx animals (Barton
et al., 2002; Shavlakadze et al., 2004). Likewise, co−injection
of the rAAV−microdystrophin and rAAV−mIGF−1 vectors
resulted in increased muscle mass and strength, reduced
myofibers degeneration, and increased protection against
contraction−induced injury (Abmayr et al., 2005). However, no
specific genes and regulatory circuitries that could account for
the observedmorpho-functional benefits inmdx/mIGF-1muscle
have been characterized.
In this work we took advantage of mdx/mIGF-1 mice to
define whether, independently of dystrophin expression, the
modulation of the dystrophic microenvironment by mIGF-1
expression has some effect on miRNAs expression.
Materials and Methods
Mice
Animal model used: 4 week-old C57Bl/10 (control strain) mice,
4 week-old mdx and mdx/mIGF-1 (Barton et al., 2002) mice.
Mdx female mice (Jackson Laboratories) were bred with IGF-1
transgenic male mice (mIGF-1) (Musarò et al., 2001), resulting
in a group of mice homozygous for the IGF-1 gene and the
X-linked mdx mutation (mdx/mIGF-1) (Barton et al., 2002).
Mice were maintained according to the institutional guidelines
of the animal facility of the unit of Histology and Medical
Embryology. All animal experiments were approved by the ethics
committee of Sapienza University of Rome-Unit of Histology
and Medical Embryology and were performed in accordance
with the current version of the Italian Law on the Protection of
Animals.
RNA Extraction and Real Time PCR Analysis
Total RNA was prepared from liquid nitrogen powdered
diaphragms homogenized with tissue lyser (QIAGEN)
in TriRiagentTM (Sigma). To synthesize single-stranded
cDNA, 10 ng of total RNA were reverse transcribed using
the TaqMan® MicroRNA Reverse Transcription Kit (Applied
Biosystem), while double-stranded cDNA was synthesized
with the QuantiTect Reverse Transcription kit (Qiagen).
miRNA and mRNA analysis were performed on an ABI
PRISM 7500 SDS (Applied Biosystems), using specific TaqMan
assays (Applied Biosystems). Relative quantification was
performed using as endogenous controls U6 snRNA for
miRNAs and HPRT1 for mRNAs. The relative expression was
calculated using the 2-DDCt method (Livak and Schmittgen,
2001).
Protein Extraction, Western Blot Analysis
Diaphragm muscles from at least 3 animals/strain (wild
type, mdx, and mdx/mIGF-1 mice) were homogenized
in modified lysis buffer (Tris-HCl, pH 7.5/20 mM,
EDTA/2 mM, EGTA/2 mM, sucrose/250 mM, DTT/5 mM,
Triton-X/0.1%, PMSF/1 mM, NaF/10 mM, SOV4/0.2 mM,
cocktail protease inhibitors/1X (Sigma)). Muscle lysates
were processed as previously described (Pelosi et al.,
2007). Filters were blotted with antibodies against: HDAC2
(Santa Cruz Biotechnology, INC), HADAC4 (Santa Cruz
Biotechnology, INC) and αTubulin (Sigma). Signals
were captured by ChemiDoc-It® Imaging System (UVP,
LLC) and densitometric analysis were performed with
VisionWorks® LS Image Acquisition and Analysis Software
(UVP, LLC).
Statistical Analysis
Statistical analysis was performed with GraphPad Prism
Software. All data, if not differently specified, were expressed
as mean ± SEM. Difference among groups were assessed with
one-way ANOVA with a Bonferroni post test or Dunn’s post
Test, and between pairs with Mann-Whitney test or Student’s
t test assuming two-tailed distributions. Each data shown in qRT-
PCR was performed on at least four different samples/animals in
biological duplicates. Sample size was predetermined based on
the variability observed in preliminary and similar experiments.
All experiments requiring animal models were subjected to
randomization based on litter. p< 0.05 is considered statistically
significant.
Results
mIGF-1 Modulates the Expression of miRNAs
and Factors Associated with Regeneration
In this study, we aimed to identify miRNAs involved in the
pathologic phenotype of young (4 weeks of age) mdx mice and
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to verify whether mIGF-1 expression was able to modulate the
miRNAs’ signature of dystrophic muscle.
Dystrophic-signature miRNAs has been divided into
three main classes: degenerative miRNAs (miR-1, miR-
29c, and miR-135a), regeneration miRNAs (miR-31, miR-
34c, miR-206, miR-335, miR-449, and miR-494), and
inflammatory miRNAs (miR-222 and miR-223) (Greco et al.,
2009).
Moreover, these groups of miRNAs play important and
crucial roles in tissue proliferation, differentiation, and
homeostasis. In particular miR-1 and miR-206, classified as
myomiRs on the basis of their selective expression in skeletal
and cardiac muscles, regulate muscle satellite cells proliferation
and differentiation, by repressing Pax-7 (Chen et al., 2010).
miR-29 regulates collagens and elastin and therefore controls
fibrogenesis (van Rooij et al., 2008). miR-31 might have different
roles; it is strongly induced in ischemia damaged myofibers,
it plays a fundamental role in postnatal vascular repair (Greco
et al., 2009; Wang et al., 2014), regulates both dystrophin
expression (Cacchiarelli et al., 2011) and the progression
of satellite cells toward differentiation (Crist et al., 2012).
miR-34c is strongly induced in ischemia damaged myofibers
(Greco et al., 2009) and it promotes cell cycle withdrawal
and apoptosis (Corney et al., 2007). miR-221 and miR-222
have antiangiogenic properties and play important role in the
regulation of vascular inflammation (Poliseno et al., 2006).
Moreover, miR-221 and miR-222 might regulate skeletal muscle
differentiation (Fasanaro et al., 2010). miR-335 and miR-449
are potent mediators of cell differentiation (Lizé et al., 2011;
Tomé et al., 2011), whereas miR-494 has been proven critical for
the myocytes’ adaptation and survival during hypoxia/ischemia
(Han et al., 2011).
Based on the dystrophic-signature miRNAs (Greco et al.,
2009) and on the specific properties of selected miRNAs, at first,
we defined and compared the miRNAs expression profile of
dystrophic diaphragmmuscle derived from 4-week-old wild type
and mdx mice.
We observed that all degenerative- miRNAs were
down-regulated in diaphragm of 4-week-old mdx compared to
wild type mice (Figure 1A), whereas most of the regeneration-
miRNAs reveal a differentially expression pattern in the
diaphragm of 4-week-old mdx mice, compared to wild
type littermates (Figures 1B–F). In particular, miR-31 and
miR-34c were not modulated (Figures 1B,C); miR-206
was up-regulated (Figure 1D) and miR-449 and miR-335
were down-regulated (Figures 1E,F) in the diaphragm of
4-week-old mdx mice. The inflammatory miRNAs (miR-222
miR-223) had a similar level of expression between mdx and
FIGURE 1 | miRNAs expression profile in diaphragm muscle of young
mdx mice. (A) qRT-PCR analysis for the expression of miRNAs classified as
degenerative miRNAs (Greco et al., 2009) (miR-1, miR-29c, miR-29b and
miR-135a) performed on diaphragm muscles from wild-type (WT) and mdx
mice at 4 weeks of age. All miRNAs were significantly down-regulated in
dystrophic diaphragm of young mdx mice compared to WT. **p < 0.005,
*p < 0.05. (B–F) qRT-PCR analysis for the expression of miRNAs classified
as regeneration miRNAs (Greco et al., 2009), such as miR-31 (B), miR-34c
(C), miR-206 (D), miR-449 (E) and miR-335 (F), in diaphragm of 4-week old
WT and mdx mice. (G,H) qRT-PCR analysis for the expression of miRNAs
classified as inflammatory miRNAs (Greco et al., 2009), namely miR-222
(G) and miR-223 (H) in diaphragm muscles from WT and mdx mice at 4
weeks of age. For all graphs, relative expressions were normalized to U6
snRNA and shown with respect to WT set to a value of 1. Values represent
mean ± SEM; n = 4–7 per group. p values using Student’s t test assuming
two-tailed.
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wild type mice. (Figures 1G,H). These data indicate that in
diaphragm of young mdx mice the dystro-miRNAs have a
specific pattern of expression that might correlate with the onset
of dystropathology.
Muscle specific expression of mIGF-1 plays important
anabolic role in skeletal muscle, promoting muscle growth and
regeneration (Musarò et al., 2001, 2004; Pelosi et al., 2007) and
counteracting muscle wasting in mdx dystrophic mice (Barton
et al., 2002).
We verified whether mIGF-1 was able to modulate the
expression of deregulated dystro-miRNAs in the diaphragm
muscle of 4-week-old mdx mice.
QRT-PCR analysis revealed that miRNAs classified within
the degenerative group, namely miR-1, miR-29b, miR-29c, and
miR-135a (Greco et al., 2009) were expressed in similar manner
in diaphragm muscle of both mdx and mdx/mIGF-1 mice
(Figure 2A). This supports the evidence that there is a group
of miRNAs that are strictly dependent on dystrophin expression
(Cacchiarelli et al., 2010).
In contrast, mIGF-1 overexpression modulated regenerative
miR-449 and miR-206 (Figures 2C,D) but not miR-335
expression (Figure 2B). In particular, we observed a down-
regulation of miR-449 (Figure 2C), and an up-regulation of miR-
206 (Figure 2D) in the diaphragm of 4-week-old mdx/mIGF-1
mice, compared to mdx littermates.
The up-regulation of the myomiR 206 suggests that mIGF-1
stabilizes the differentiated muscle phenotype, reducing the
cycle of regeneration and degeneration and therefore the
need to continuously activate satellite cells. We have recently
demonstrated that in mdx mice, miR-206 facilitates satellite cell
differentiation by restricting their proliferative potential through
the repression of Pax-7 expression (Cacchiarelli et al., 2010). To
support this hypothesis, we evaluated the expression of Pax-7,
a marker of quiescent and activated satellite cells (Seale and
Rudnicki, 2000), in both mdx and mdx/mIGF-1 mice. Pax-7
expression showed an inverse correlation with miR-206 levels,
since it was lowly expressed in the diaphragm of mdx/mIGF-1
mice compared to mdx littermates (Figure 2E).
FIGURE 2 | mIGF-1 positively modulates regenerative miRNA
expression in dystrophic muscle. (A) Total RNA from diaphragm
of 4-week-old mdx/mIGF-1 mice and mdx littermates (control), were
analyzed by qRT-PCR for degenerative-miRNAs expression (miR-1,
miR-29c, miR-29b and miR-135a). Relative expressions were
normalized to U6 snRNA and shown with respect to mdx set to a
value of 1. Values represent mean ± SEM; n = 5–7 per group.
(B–D) Histograms show relative expression of regeneration- miRNAs:
miR-335 (B), miR-449 (C), and miR-206 (D), measured by
qRT-PCR in diaphragm of 4-week-old mdx and mdx/mIGF-1 mice.
Relative expressions were normalized to U6 snRNA and shown with
respect to mdx littermates, set to a value of 1. Values represent
mean ± SEM; n = 4–7 per group. p values using Student’s t test
assuming two-tailed. (E,F) Graphs show the fold change of Pax-7
(E) and utrophin (F) expression levels from real time PCR analysis
performed on diaphragm muscles of WT, mdx and mdx/mIGF-1
mice at 4 weeks of age. Relative expressions were normalized to
HPRT1 and shown with respect to WT set to a value of 1 (dashed
line). Values represent mean ± SEM; n = 4–6 per group. #p < 0.05
using one way ANOVA.
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Another potential target of miR-206 is utrophin (Rosenberg
et al., 2006), a gene supposed to counteract the absence of
dystrophin. Real time PCR analysis revealed that utrophin
was up-regulated in both mdx and mdx/mIGF-1 diaphragm
(Figure 2F); however, we did not observe significant differences
in utrophin gene expression between the two experimental
models (Figure 2F), suggesting that the up-regulation of miR-
206 did not impinge the expression of utrophin.
These data suggest that mIGF-1 might enhance the
differentiation program of dystrophic fibers, inducing an
up-regulation of miR-206.
mIGF-1 Stimulates the Maturation of the
Myogenic Program
To further support this hypothesis, we evaluated other relevant
markers of the myogenic program and muscle maturation. A key
myogenic factor that triggers myoblast differentiation is MyoD
(Tapscott, 2005; Musarò, 2014), which resulted significantly
up-regulated in the diaphragm of 4-week-old mdx/mIGF-1
mice compared to that of mdx littermates (Figure 3A).
Interestingly, MyoD showed a direct correlation with miR-
206 levels (Figure 2D), confirming evidences that miR-206 is
up-regulated by MyoD (Rosenberg et al., 2006) and targets
Pax-7 mRNA (Cacchiarelli et al., 2010). Through this miR-
206-mediated negative feedback mechanism, MyoD facilitates
progression toward terminal differentiation (Chen et al., 2010;
Hirai et al., 2010).
Myogenin is the myogenic factor that function downstream of
MyoD and plays a critical role in the terminal differentiation of
myoblasts (Nabeshima et al., 1993). Myogenin expression
resulted significantly up-regulated in the diaphragm
of mdx/mIGF-1 mice compared to mdx littermates
(Figure 3B).
The final stage of skeletal muscle differentiation and
maturation program is dependent on the concerted action of
myogenic factors, such as MEF-2C and MRF4.
Real time PCR analysis revealed a significant increase of
both MEF-2C and MRF4 transcripts in the diaphragm from
4-week-old mdx/mIGF-1 mice, compared to mdx littermates
(Figures 3C,D), suggesting that mIGF-1 favors the completion
of the myogenic program.
To support this hypothesis, we analyzed relevant markers
of a mature muscle phenotype such as β-enolase (ENO3) and
MCK, which are down-stream myogenic factors of MEF-2C and
myogenin. MCK and ENO3 expression levels were significantly
enhanced in the diaphragm from 4-week-old mdx/mIGF-1 mice,
compared to mdx littermates (Figures 3E,F).
These data suggest that the maturation of the myogenic
program, which is affected by the absence of dystrophin
expression, is promoted by mIGF-1 expression.
To further support the pro-myogenic activity of mIGF-1, we
analyzed the expression of another key player that functions
during both differentiation and homeostatic maintenance of
skeletal muscle tissues, namely the non-muscle-specific miR-24
FIGURE 3 | mIGF-1 promotes maturation of the myogenic program in
diaphragm muscle of mdx mice. (A–F) Expression of MyoD (A), Myogenin
(B), MEF-2C (C), MRF4 (D), β-enolase (ENO3) (E), and MCK (F), evaluated by
real time PCR analysis in diaphragms of indicated genotypes at 4 weeks of age.
Relative expressions were normalized to HPRT1 and shown with respect to WT,
set to a value of 1. Values represent mean ± SEM; n = 4–7 per group.
*p < 0.05, **p < 0.005, ***p < 0.0005, #p < 0.05, ##p < 0.005 using one way
ANOVA. (G,H) Histograms show miR-24 (G) and miR-31 (H) expression,
analyzed by qRT-PCR in diaphragm muscles from WT, mdx, and mdx/mIGF-1
mice at 4 weeks of age. Expression levels were normalized to U6 snRNA and
shown with respect to WT set to value of 1. For all graphs, values represent
mean ± SEM; n = 5–7 per group. p values using one way ANOVA.
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(Sun et al., 2008). In fact, in addition to being strongly induced
during myogenesis, miR-24 expression is maintained at high
levels in terminally differentiatedmuscle tissues (Sun et al., 2008).
Figure 3G shows that miR-24 was significantly up-regulated in
the diaphragm of 4-week-old mdx/mIGF-1 mice compared to
mdx littermates.
Of interest was also the observation that local expression
of mIGF-1 enhanced miR-31 expression in the diaphragm of
mdx/mIGF-1 mice, compared to mdx littermates (Figure 3H).
It has been demonstrated that miR-31 targets Myf5, maintaining
the quiescence of satellite cell. In activated satellite cells the levels
of miR-31 are reduced, leading to Myf5 protein accumulation
and satellite cells activation/proliferation (Sun et al., 2008; Crist
et al., 2012).
mIGF-1 Prevents the Activation of a Chronic
Inflammatory Response
Muscle necrosis and inflammation became significantly apparent
at 3–4 weeks of age in mdx mice (Tidball and Villalta, 2010).
It has been reported that miR-222 and miR-223, classified
as inflammatory miRNAs (Greco et al., 2009) were highly
expressed in damaged areas of the ischemic muscle and adult
mdx mice, whereas they were not induced in muscles of
newborn mdx mice (Greco et al., 2009). We did not observe
significant change in miR-222 and miR-223 expression in mdx
nor mdx/mIGF-1 mice (Figures 4A,B), suggesting that these
two specific miRNAs were not modulated in the diaphragm
of 4-week-old dystrophic mice and by the expression of
mIGF-1.
It is known that M1 macrophages predominate during the
early, acute stage of inflammation in mdx muscle (Villalta
et al., 2009) and the proinflammatory cytokine tumor necrosis
factor alpha (TNF-α), strongly contributes to necrosis in the
dystrophin-deficient fibers of the mdx mice (De Paepe and De
Bleecker, 2013). Real time PCR analysis revealed a significant
down-regulation of TNF-α in the diaphragm of mdx/mIGF-1
mice, compared to mdx littermates (Figure 4C). This suggests
that mIGF-1, modulating specific factors of M1 phenotype,
might attenuate the severity of muscle pathology in muscular
dystrophy. To further support this hypothesis we analyzed miR-
16 expression, which induces TNF-α mRNA degradation (Jing
et al., 2005). miR-16 was indeed strongly downregulated in the
diaphragm of 4-week-old mdx compared to wild type, while its
expression was rescued in mdx/mIGF-1 diaphragm (Figure 4D).
Another chemokine that mediates the cytotoxic activities
of M1 macrophages in DMD is MCP-1 (Villalta et al., 2009).
Real time PCR analysis revealed a significant downregulation of
MCP-1 in the diaphragm ofmdx/mIGF-1mice compared tomdx
littermates (Figure 4E), indicating a reduction of macrophage-
dependent inflammatory response in dystrophic niche. We did
not observe any modulation of the inflammatory cytokines in the
diaphragm of both healthy wild type and mIGF1 transgenic mice
(data not shown).
These data suggest that mIGF-1 contributes to amelioration
of dystrophic niche, interfers with the activation of a chronic
inflammatory program, and guarantees a functional homeostatic
maintenance of dystrophic muscle.
FIGURE 4 | mIGF-1 modulates factors associated with the
inflammatory response in dystrophic muscle. (A,B) Graphs show
inflammatory -miR-222 (A) and miR-223 (B) expressions analyzed by
qRT-PCR in diaphragm muscles from WT, mdx, and mdx/mIGF-1 mice at 4
weeks of age. Relative expressions were normalized to U6 snRNA and shown
with respect to WT set to a value of 1. Values represent mean ± SEM; n = 5–7
per group. (C) Expression of TNF-α evaluated by real time PCR analysis, in
diaphragms of indicated genotypes at 4 weeks of age. Relative expressions
were normalized to HPRT1 and shown with respect to WT, set to a value of 1.
Values represent mean ± SEM; n = 5–7 per group. *p < 0.05, #p < 0.05 by
one way ANOVA. (D) miR-16 expression measured by qRTPCR in diaphragm
of 4-week-old WT, mdx and mdx/mIGF-1 mice. Relative expressions were
normalized to U6 snRNA and shown with respect to WT set to a value of 1.
Values represent mean ± SEM; n = 5–7 per group. *p < 0.05, #p < 0.05 by
one way ANOVA. (E) Relative expression analysis for MCP-1, measured by
real time PCR in diaphragms of indicated genotypes at 4 weeks of age.
Relative expressions were normalized to HPRT1 and shown with respect to
WT, set to a value of 1. Values represent mean ± SEM; n = 5–6 per group.
*p < 0.05, #p < 0.05 by one way ANOVA.
mIGF-1 Modulates Factors Associated with
Adipogenic Differentiation
DMD is characterized by membrane fragility, myofibers
necrosis and replacement of skeletal muscle by fibrous and
fatty connective tissue, due to failed regeneration (Grounds
et al., 2008). In order to verify whether mIGF-1 acts as an
environmental cues controlling adipogenic differentiation, we
analyzed relevant markers of molecular mediators of adipogenic
phenotype, including PPARγ and HADCs. PPARγ is a master
gene involved in adipogenic differentiation (Joe et al., 2010;
Uezumi et al., 2010). In addition, it has been demonstrated
that the reduction of adipogenic differentiation in young
mdx mice, through Histone Deacetylase inhibition, counteracts
DMD progression (Mozzetta et al., 2013; Saccone et al.,
2014).
Real time PCR analysis revealed a strong down-regulation
of PPARγ in the diaphragm of 4-week-old mdx/mIGF-1
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mice, compared to mdx littermates (Figure 5A). Moreover,
we analyzed the expression of the upstream modulators of
the fibro-adipogenic progenitors (FAPs) phenotype in young
mdx mice, such as HADCs and myomiRs (Colussi et al.,
2008; Cacchiarelli et al., 2010; Saccone et al., 2014). While
HDAC4 did not show change, we observed a significantly
reduction of HADC2 in mdx/mIGF-1 compared to mdx
muscle (Figures 5B,C). Moreover, myomiR-206 (Figure 2D)
and myomiR-133a (Figure 5D), which ultimately lead to the
activation of a pro-myogenic program at the expense of the
fibro-adipogenic phenotype (Saccone et al., 2014), were strongly
up-regulated in mdx/mIGF-1 compared to mdx diaphragm.
The molecular mechanisms that, in concert with environmental
cues, control the identity and activity of muscle cells involve
the BAF60C-based SWI/SNF complex (Saccone et al., 2014).
We observed a significant up-regulation of BAF60C in the
muscle of mdx/mIGF-1 mice compared to mdx littermates
(Figure 5E).
These data suggest that mIGF-1 creates a qualitative
environment that favors muscle differentiation and maturation.
Discussion
The major findings of this study indicate that muscle-specific
expression of IGF-1 (mIGF-1) can counter aspects of the
muscular dystrophy associated with the loss of dystrophin,
modulating relevant molecules of the genetic and epigenetic
circuitries in the mdx dystrophic mouse model.
The mdx mouse strain, lacking a functional dystrophin gene,
has served as the animal model for human Duchenne and
Becker muscular dystrophies (Hoffman et al., 1987). Moreover,
it provides a convenient system to test possible therapeutic
interventions as well as to select molecular markers that could be
useful to monitor disease progression and therapeutic outcomes
(Grounds et al., 2008).
The choice to analyse the effect of mIGF-1 in the diaphragm
of young (4 weeks of age) dystrophic mdx mice was based on
the evidence that at this age there is an acute onset of pathology
(increased myofiber necrosis and elevated blood CK), in which
mdx mice display muscle weakness similarly to DMD patients
(Grounds et al., 2008). Moreover, the diaphragm represents one
of the most severely compromised muscle in mdx mice, more
closely resembling the severe pathology of DMD (Stedman et al.,
1991; Lynch et al., 1997; Grounds et al., 2008).
Among epigenetic factors, miRNAs represent a class
of highly conserved small molecules of about 20–23
nucleotides long that regulate gene expression at post-
trasciptional level. miRNAs participate in the regulation
of several essential biological processes such as cell
proliferation and apoptosis, cell differentiation, stress
response, and immune regulation (Sayed and Abdellatif,
2011). Several miRNAs show a tissue or developmental
FIGURE 5 | mIGF-1 modulates factors associated with adipogenic
differentiation. (A) Graph shows the fold change of PPARγ expression levels
from qPCR analysis performed on diaphragm muscles of WT, mdx and
mdx/mIGF-1 mice at 4 week of age. Relative expressions were normalized to
HPRT1 and shown with respect to WT, set to a value of 1 (dashed line). Values
represent mean ± SEM; n = 4–6 per group. *p < 0.05 using one way ANOVA.
(B,C) Representative images of western blot analysis for the expression of
HADAC4 (right panel, B) and HADAC2 (right panel, C) on diaphragm of
4-week-old wild type (WT), mdx, and mdx/mIGF-1 mice. Left panels show
densitometric analysis. Expression levels were normalized to HPRT1 and shown
with respect to WT, set to a value of 1 (dashed line). Values represent mean ±
SEM; n = 5–6 per group. *p < 0.05 using one way ANOVA. In (B) and (C) the
lane were run on the same gel but were non contiguous. (D) miR-133a
expression measured by qRTPCR in diaphragm of 4-week-old wild type (WT),
mdx and mdx/mIGF-1 mice. Relative expressions were normalized to U6
snRNA and shown with respect to WT set to a value of 1 (dashed line). Values
represent mean ± SEM; n = 4–7 per group. **p < 0.005, by one way ANOVA.
(E) Graph shows the fold change of BAF60C expression levels from qPCR
analysis performed on diaphragm muscles of WT, mdx and mdx/mIGF-1 mice
at 4 week of age. Relative expressions were normalized to HPRT1 and shown
with respect to WT, set to a value of 1 (dashed line). Values represent mean ±
SEM; n = 4–5 per group. *p < 0.05 using one way ANOVA.
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FIGURE 6 | A schematic model depicting the effects of mIGF-1
overexpression on dystrophic muscle. mIGF-1 overexpression ameliorates
dystrophic niche, reducing inflammation, modulating factors associated with
adipogenic differentiation, and improving differentiation and maturation of
regenerating myofibers. All of this contributes to functional homeostatic
maintenance of dystrophic muscle.
specific expression pattern and are present in complex
regulatory networks to govern stem cells function, tissue
differentiation and maintenance of cell identity during
development and adult life (Fazi and Nervi, 2008). Thus,
altered expression of miRNAs may be associated with different
pathologies.
Several studies have analyzed the expression of miRNAs in the
dystrophic mdx mouse model, (Greco et al., 2009; Cacchiarelli
et al., 2010; Roberts et al., 2012). The findings point to an
unexpected layer of complexity in the mdx mouse miRNA
transcriptome. The differences in miRNAs expression, observed
in different studies using the same mdx mouse model, can be
justified considering different parameters, namely the rescue of
the dystrophin-mediated signaling, the age of mdx mice, and the
severity of muscle districts (McCarthy et al., 2007; Grounds et al.,
2008; Yuasa et al., 2008; Greco et al., 2009; Cacchiarelli et al.,
2010).
In our study, we verified whether mIGF-1 expression was
able tomodulate dystrophic-signaturemiRNAs in the diaphragm
muscle of 4-week-old mdx mouse model.
It has been demonstrated that when dystrophin synthesis
was restored the levels of miR-1, miR-133a, miR-29c, miR-
30c, and miR-206 increased, while miR-23a expression did not
change (Cacchiarelli et al., 2010). At variance with the other
myomiRs, miR-206 was highly expressed in mdx as well as in
exon-skypping-treated animals (Cacchiarelli et al., 2010). On the
other hand, local injection of the NO-donor nitroglycerin (NTG)
in mdx mice increased miR-1 and miR-29 expression, whereas
did not modulate miR-206 (Cacchiarelli et al., 2010).
In our study, we revealed that mIGF-1 expression was not able
to modulate miR-29 and miR-1 expression in the mdx mouse
model, further indicating that the expression of these miRNAs is
strictly linked to the dystrophin rescue (Cacchiarelli et al., 2010).
Our data with mdx/mIGF-1 mice also support the evidences
that miR-206, which it has been demonstrated to be expressed
before dystrophin synthesis starts (Cacchiarelli et al., 2010),
well correlates with its expression being independent from
the Dystrophin/nNOS/HDAC2 pathway and might depict the
potential of muscle regeneration and maturation activated by
mIGF-1.
On the contrary, McCarthy et al. (2007) proposed that
increased miR-206 expression may contribute to the chronic
pathology of mdx diaphragm. In addition, miR-206 seems to be
primarily involved in satellite cell impairment of dystrophic dogs,
although its precise role needs to be elucidated (La Rovere et al.,
2014). The apparent discrepancy among these studies and our
findings can be justified considering that the up-regulation of
miR-206 in the diaphragm of mdx/mIGF-1 might be related to
its specific function in muscle differentiation instead in muscle
pathology. This consideration is supported by the evidence that
the other markers of muscle differentiation and maturation are
positively modulated in the mdx/mIGF-1 mice compared to mdx
littermates.
The transition from cell proliferation to differentiation
and maturation involves the downregulation of proliferative-
associated genes. Sustained expression of Pax-7 in satellite
cells delays the onset of myogenesis, and elevated expression
of Pax-7 in primary myoblasts inhibits the expression of
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MyoD, preventing myogenin induction and muscle terminal
differentiation (Olguin and Olwin, 2004; McFarlane et al., 2008).
We observed, in mdx/mIGF-1 mice compared to mdx
animals, a downregulation of Pax-7 expression, associated
with an increased in MyoD, myogenin, MCK and β-enolase
expression, which represent relevant markers of differentiated
andmore mature muscle phenotype (Musarò, 2014). In addition,
these data were strengthened by the up-regulation of miR-24 in
mdx/mIGF-1 mice compared to mdx littermates. miR-24 is a
non-muscle-specific miRNA involved in myogenesis; it is highly
expressed in terminally differentiated muscle and it functions
during both differentiation and homeostatic maintenance (Sun
et al., 2008).
Our data are consistent with a model in which mIGF-1
stimulates muscle differentiation and maturation (Musarò and
Rosenthal, 1999), by promoting the up-regulation of MyoD
that, in turn, activates the expression of miR-206 (Rosenberg
et al., 2006). miR-206 potently enhances the myogenic program
by limiting and refining the expression of Pax-7 in myogenic
progenitor cells (Chen et al., 2006, 2010; Cacchiarelli et al., 2010).
All of these data suggest that the maturation of the myogenic
program and the homeostatic maintenance of dystrophic muscle
tissues, which are severely affected by the absence of dystrophin
expression, are facilitated by mIGF-1 expression. This might
result in reduction in the cycle of regeneration and degeneration,
which characterize the mdx dystrophic muscle, and therefore the
need to continuously activate satellite cells. DMD is a disease
of accelerated damage to muscle that causes the satellite cells
to eventually be used up. Thus, mIGF-1, stabilizing the muscle
phenotype, reduces the need to continuous use satellite cells,
delaying the progression of disease.
Dystrophin is expressed not only in muscle cells but also
in vascular endothelial cells (ECs). In DMD, the signaling
defects produce inadequate tissue perfusion caused by functional
ischemia due to a diminished ability to respond to shear
stress induced endothelium-dependent dilation. It has been
recently demonstrated that vascular densities is decreased
and angiogenesis impaired in the muscles of mdx mice
(Matsakas et al., 2013; Palladino et al., 2013; Shimizu-
Motohashi and Asakura, 2014). Thus, increasing the density
of the underlying vascular network in dystrophic muscle
might be relevant therapeutic approach to reduce functional
ischemia and to strength the muscle niche (Ennen et al.,
2013).
In our study, we observed that mIGF-1 modulates miR-31,
which is involved in vascular remodeling, regulating the activity
of endothelial progenitor cells, and it plays a fundamental role
in postnatal vascular repair (Greco et al., 2009; Wang et al.,
2014). We can speculate that mIGF-1, modulating relevant
players of vascular remodeling, might enhance vascularization in
mdx mice.
Control of the inflammatory response is a critical component
of efficient muscle regeneration. A balance must therefore
be struck between excessive and insufficient inflammatory
action. Sustained inflammatory response represents one of
the pathogenic events associated with muscular dystrophy
(Tidball and Wehling-Henricks, 2005; Tidball and Villalta,
2010). Release of cytokines, especially TNF-α during the
inflammatory response has a strong influence on the normal
progression of the proliferative stage of inflammatory cells,
and on the transition from acute to chronic inflammatory
response (Waheed et al., 2005; De Paepe and De Bleecker,
2013).
In our study, we revealed that mIGF-1 up-regulated miR-16,
which in turn stimulates the degradation of TNF-α and the
inhibition of MCP-1 expression.
Of note, TNF-α and MCP-1 are significantly associated
with clinical outcome of DMD patients (De Pasquale et al.,
2012).
Overall our study provides additional insights into the
complex effects of mIGF-1 on muscle homeostasis and diseases
and reveals the potential miRNA signature associated with
mIGF-1 expression in mdx dystrophic mice. However, although
these results point towards some mechanisms of action of
mIGF-1, the elevated number of potential targets of these
miRNAs make these mechanisms only mere suggestions.
Our work is consistent with a model (Figure 6) in which
overexpression of mIGF-1 confers robustness to dystrophic
muscle, impedes the activation of a chronic inflammatory
response, activates the circuitry of muscle differentiation and
maturation. This results in a functional homeostaticmaintenance
of dystrophic muscle.
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